MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
China Pharma Holdings ROA Ratio 2011-2026 | CPHI
Annual ROA Ratio China Pharma Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.28 | -31.81 | -18.69 | -22.34 | -15.01 | -13.58 | -93.1 | -23.69 | -32.15 | -11.69 | -15.85 | -19.72 | -12.69 | 2.83 | 12.32 | 17.77 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.77 | -93.1 | -17.98 |
Quarterly ROA Ratio China Pharma Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.02 | -21.79 | -27.75 | -28.98 | -23.45 | -27.23 | -21.67 | -11.58 | -11.58 | -16.46 | -16.36 | -17.47 | -14.73 | -19.28 | -18.53 | -17.44 | -12.55 | -17.33 | -12.72 | -11.72 | -7.85 | -11.0 | -9.99 | -11.93 | -8.8 | -12.89 | -11.96 | -8.84 | -6.96 | -10.62 | -10.35 | -9.74 | -9.09 | -11.32 | -10.78 | -8.94 | -7.33 | -4.32 | -0.93 | -1.99 | -0.01 | -5.24 | -15.39 | -18.52 | -14.34 | -20.42 | -18.02 | -10.7 | -8.73 | -5.14 | 3.74 | 8.29 | 8.11 | 10.21 | 9.86 | 10.33 | 8.61 | 2.1 | 3.24 | 3.26 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.33 | -28.98 | -9.82 |
ROA Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
-1.84 | $ 5.87 | 6.53 % | $ 87.2 M |  USA |
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-30.55 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
-157.66 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-25.07 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-48.08 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-45.36 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-0.24 | $ 2.74 | 0.37 % | $ 1.05 B | Canada |
 |
Harrow Health
HROW
|
-1.29 | $ 33.0 | 0.12 % | $ 1.21 B | USA |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
6.18 | $ 2.66 | - | $ 337 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 23.35 | -0.55 % | $ 1.08 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
0.6 | $ 5.47 | 0.37 % | $ 2 B | Canada |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.04 | -2.8 % | $ 112 M | Canada |
 |
Tilray
TLRY
|
-33.73 | $ 5.29 | -3.11 % | $ 3.27 B | Canada |
 |
Solid Biosciences
SLDB
|
-74.97 | $ 6.62 | 1.85 % | $ 579 M | USA |
 |
Aurora Cannabis
ACB
|
0.19 | $ 3.46 | -2.81 % | $ 190 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 1.1 | 3.77 % | $ 1.37 M | USA |
 |
Jupiter Wellness
JUPW
|
-166.41 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.14 | $ 1.12 | -0.88 % | $ 107 M | Canada |
 |
Evolus
EOLS
|
-22.86 | $ 6.09 | -5.58 % | $ 393 M | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.45 | -1.36 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
3.99 | $ 8.45 | 0.96 % | $ 433 M | USA |
 |
Veru
VERU
|
-76.17 | $ 2.35 | 5.86 % | $ 34.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-31.31 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-19.59 | $ 0.76 | -2.32 % | $ 3.06 M | USA |
 |
Assertio Holdings
ASRT
|
-11.38 | $ 23.44 | 0.3 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
21.06 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-61.05 | $ 7.04 | -2.36 % | $ 278 M | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-32.94 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-14.58 | $ 0.73 | 3.0 % | $ 36.5 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-9.45 | $ 16.65 | 1.15 % | $ 19.4 B | USA |
 |
Zomedica Corp.
ZOM
|
-64.44 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-9.3 | $ 0.79 | -2.06 % | $ 28.4 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
-1.51 | $ 2.12 | 0.47 % | $ 24.5 M | USA |